{"data":[{"accessionNo":"0001950047-26-009883","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"ASIF ALI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":58629,"aggregateMarketValue":8264930.13,"unitsOutstanding":64708285,"approxSaleDate":"2026-09-30","exchange":"NASDAQ","filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-006422","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9000,"aggregateMarketValue":1035270,"unitsOutstanding":64311373,"approxSaleDate":"2026-06-23","exchange":"NASDAQ","filedAt":"2026-06-23","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-005894","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9000,"aggregateMarketValue":952830,"unitsOutstanding":64311373,"approxSaleDate":"2026-06-10","exchange":"NASDAQ","filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-005290","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9000,"aggregateMarketValue":903690,"unitsOutstanding":64311373,"approxSaleDate":"2026-05-29","exchange":"NASDAQ","filedAt":"2026-05-29","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-004264","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"BRYAN M  & COURTNEY L GIRAUDO RT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":11130,"aggregateMarketValue":1113000,"unitsOutstanding":64311373,"approxSaleDate":"2026-05-08","exchange":"NASDAQ","filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-004220","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"BRYAN GIRAUDO","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":36000,"aggregateMarketValue":3604968,"unitsOutstanding":64311373,"approxSaleDate":"2026-05-07","exchange":"NASDAQ","filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-004218","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"BRYAN M  & COURTNEY L GIRAUDO RT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":12000,"aggregateMarketValue":1200873.6,"unitsOutstanding":64311373,"approxSaleDate":"2026-05-07","exchange":"NASDAQ","filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001104659-26-046107","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc.","ticker":"PTGX","personName":"Asif Ali","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney Operations Department","unitsToSell":1750,"aggregateMarketValue":184572.5,"unitsOutstanding":63808716,"approxSaleDate":"2026-04-20","exchange":"NASDAQ","filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001968582-26-000318","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc.","ticker":"PTGX","personName":"Dinesh Patel","relationship":"CEO","securityClass":"Common","broker":"J.P. Morgan Securities LLC","unitsToSell":54700,"aggregateMarketValue":5390138,"unitsOutstanding":63808716,"approxSaleDate":"2026-03-24","exchange":"Nasdaq","filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-001404","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"LEWIS T WILLIAMS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":18000,"aggregateMarketValue":1483495.2,"unitsOutstanding":62515666,"approxSaleDate":"2026-02-17","exchange":"NASDAQ","filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-000988","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM D WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":1673672,"unitsOutstanding":62515666,"approxSaleDate":"2026-02-06","exchange":"NASDAQ","filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-000698","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"ARTURO MOLINA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":410000,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-27","exchange":"NASDAQ","filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-000710","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"ASIF ALI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":46203,"aggregateMarketValue":3841128.28,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-27","exchange":"NASDAQ","filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-000681","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"ARTURO MOLINA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":411396,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-26","exchange":"NASDAQ","filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001968582-26-000059","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc.","ticker":"PTGX","personName":"Dinesh Patel","relationship":"CEO","securityClass":"Commom","broker":"J.P. Morgan Securities LLC","unitsToSell":108273,"aggregateMarketValue":9162061,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-23","exchange":"Nasdaq","filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-26-000655","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"ARTURO MOLINA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":13151,"aggregateMarketValue":1097115.6,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-23","exchange":"NASDAQ","filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001104659-26-005437","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc","ticker":"PTGX","personName":"DINESH V PATEL PH D","relationship":"Officer, Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney Operations Department","unitsToSell":34438,"aggregateMarketValue":2840446.24,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-20","exchange":"NASDAQ","filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001104659-26-005438","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc","ticker":"PTGX","personName":"ARTURO MOLINA MD","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney Operations Department","unitsToSell":9514,"aggregateMarketValue":784714.72,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-20","exchange":"NASDAQ","filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001104659-26-005435","issuerCik":"0001377121","issuerName":"Protagonist Therapeutics, Inc","ticker":"PTGX","personName":"Asif Ali","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney Operations Department","unitsToSell":8588,"aggregateMarketValue":708338.24,"unitsOutstanding":62515666,"approxSaleDate":"2026-01-20","exchange":"NASDAQ","filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-25-007903","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":12000,"aggregateMarketValue":804480,"unitsOutstanding":62211318,"approxSaleDate":"2025-10-10","exchange":"NASDAQ","filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"},{"accessionNo":"0001950047-25-007415","issuerCik":"0001377121","issuerName":"PROTAGONIST THERAPEUTICS, INC.","ticker":"PTGX","personName":"WILLIAM WADDILL","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4000,"aggregateMarketValue":248800,"unitsOutstanding":62211318,"approxSaleDate":"2025-09-22","exchange":"NASDAQ","filedAt":"2025-09-22","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx"}],"updatedAt":"2026-11-04T04:00:43.710Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ptgx","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}